Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of -4.81% and Operating profit at -183.48% over the last 5 years
2
With a fall in Net Sales of -4.06%, the company declared Very Negative results in Sep 25
3
Risky -
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
CNY 24,007 Million (Large Cap)
NA (Loss Making)
NA
0.00%
0.40
-4.58%
0.82
Revenue and Profits:
Net Sales:
2,150 Million
(Quarterly Results - Mar 2026)
Net Profit:
-394 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.45%
0%
-11.45%
6 Months
-26.68%
0%
-26.68%
1 Year
-20.91%
0%
-20.91%
2 Years
-57.53%
0%
-57.53%
3 Years
-79.96%
0%
-79.96%
4 Years
-83.83%
0%
-83.83%
5 Years
-92.3%
0%
-92.3%
Chongqing Zhifei Biological Products Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.81%
EBIT Growth (5y)
-183.48%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
4.10
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
0.96
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
23.73%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.21%
ROE (avg)
30.14%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.64
EV to EBIT
-66.48
EV to EBITDA
-133.35
EV to Capital Employed
1.46
EV to Sales
4.82
PEG Ratio
NA
Dividend Yield
0.97%
ROCE (Latest)
-2.20%
ROE (Latest)
-2.70%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
2,150.20
1,331.00
61.55%
Operating Profit (PBDIT) excl Other Income
-362.80
-15,774.00
97.70%
Interest
85.90
87.10
-1.38%
Exceptional Items
0.00
-6.40
100.00%
Consolidate Net Profit
-393.70
-13,525.80
97.09%
Operating Profit Margin (Excl OI)
-168.70%
-11,954.40%
1,178.57%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 61.55% vs -50.85% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 97.09% vs -2,073.17% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
8,922.60
25,954.80
-65.62%
Operating Profit (PBDIT) excl Other Income
-16,691.70
2,660.90
-727.30%
Interest
337.40
192.30
75.46%
Exceptional Items
-14.20
0.20
-7,200.00%
Consolidate Net Profit
-14,745.30
1,940.50
-859.87%
Operating Profit Margin (Excl OI)
-1,930.60%
86.70%
-201.73%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -65.62% vs -50.82% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -859.87% vs -76.07% in Dec 2024
About Chongqing Zhifei Biological Products Co., Ltd. 
Chongqing Zhifei Biological Products Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






